Investing
CVR Refining, ImmunoGen Join Wednesday's 52-Week Low Club
Published:
Last Updated:
July 13, 2016: Here are four stocks trading with relatively heavy volume among 11 equities making new 52-week lows in Wednesday’s session. NYSE decliners led advancers by a small margin and Nasdaq decliners led advancers by about 3 to 2.
Avinger Inc. (NASDAQ: AVGR) fell by nearly 43% on Wednesday to post a new 52-week low of $6.52 against a high of $25.11. The stock closed at $11.43 on Tuesday night. Volume topped 2.3 million shares, more than 20 times the stock’s daily average of around 100,000. The company announced preliminary earnings and lowered guidance earlier on Wednesday.
CVR Refining LP (NYSE: CVRR) dropped about 6.9% on Wednesday to post a new 52-week low of $6.20 against a 52-week high of $22.74. Volume was about double the daily average of around 630,000. The stock closed at $6.66 on Tuesday night. The oil refiner had no specific news, but swelling supplies of gasoline have not helped refining stocks in Wednesday’s trading session.
ImmunoGen Inc. (NASDAQ: IMGN) lost nearly 3.4% to post a new 52-week low of $2.87 versus a high of $19.43. Volume totaled about 60% less than the daily average of nearly 2.3 million. The biotech firm had no specific news Wednesday.
Scynexis Inc. (NASDAQ: SCYX) slipped 6.2% on Wednesday to post a new 52-week low of $1.97 after closing at $2.10 on Tuesday. The stock’s 52-week high is $9.00. Volume reached nearly 3 times the daily average of around 150,000 shares. The company had no news.
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.